No actionable trading signal, this is a routine investor relations update. Monitor for any material disclosures that may emerge from the conferences, but no immediate action warranted.
RDY drugs
RDY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 3 $13.02entry
- T+1 · 6mo ago +1.69%α +1.29% · $13.24
- T+5 · 5mo ago +2.15%α +5.97% · $13.30
- T+20 · 5mo ago +10.45%α +11.45% · $14.38
- T+60 · 3mo ago −6.61%α −9.10% · $12.16
Price Chart
How similar events traded
Executive Summary
Dr. Reddy's filed a Form 6-K on June 3, 2026, disclosing that management will participate in two investor conferences: a group meeting organized by ICICI Securities in Mumbai on June 9, 2026, and a group meeting organized by Macquarie in Hyderabad on June 10, 2026. This is a routine disclosure of investor relations activities with no material financial information.
Key Facts
- Management to participate in ICICI Securities group meeting in Mumbai on June 9, 2026
- Management to participate in Macquarie group meeting in Hyderabad on June 10, 2026
- Both meetings are in-person group meetings with institutional investors
- No material financial data, guidance, or business developments disclosed
Financial Impact
No financial impact, routine investor conference participation with no material disclosures
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000395 |
| Document: 0001575872-26-000395-index.html | 0001575872-26-000395 |
| Document: 0001575872-26-000395.txt | 0001575872-26-000395 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers